Business Description
Bolt Biotherapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US0977021049
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.67 | |||||
Equity-to-Asset | 0.73 | |||||
Debt-to-Equity | 0.19 | |||||
Debt-to-EBITDA | -0.27 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -3.93 | |||||
Beneish M-Score | -2.19 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 209.7 | |||||
3-Year EBITDA Growth Rate | -8.8 | |||||
3-Year EPS without NRI Growth Rate | -6 | |||||
3-Year FCF Growth Rate | -5.1 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 23.88 | |||||
9-Day RSI | 27.88 | |||||
14-Day RSI | 31.28 | |||||
6-1 Month Momentum % | 26.54 | |||||
12-1 Month Momentum % | -41.74 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.68 | |||||
Quick Ratio | 5.68 | |||||
Cash Ratio | 5.46 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.2 | |||||
Shareholder Yield % | 6.72 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -661.19 | |||||
Net Margin % | -556.59 | |||||
FCF Margin % | -557.6 | |||||
ROE % | -48.86 | |||||
ROA % | -36.02 | |||||
ROIC % | -113.97 | |||||
ROC (Joel Greenblatt) % | -297.86 | |||||
ROCE % | -47.68 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2.51 | |||||
PB Ratio | 0.28 | |||||
Price-to-Tangible-Book | 0.28 | |||||
EV-to-EBIT | 0.57 | |||||
EV-to-EBITDA | 0.58 | |||||
EV-to-Revenue | -3.73 | |||||
EV-to-FCF | 0.66 | |||||
Price-to-Net-Current-Asset-Value | 0.51 | |||||
Price-to-Net-Cash | 0.54 | |||||
Earnings Yield (Greenblatt) % | 175.94 | |||||
FCF Yield % | -213.21 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Bolt Biotherapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 10.46 | ||
EPS (TTM) (€) | -1.535 | ||
Beta | 0.52 | ||
Volatility % | 43.47 | ||
14-Day RSI | 31.28 | ||
14-Day ATR (€) | 0.059345 | ||
20-Day SMA (€) | 0.96375 | ||
12-1 Month Momentum % | -41.74 | ||
52-Week Range (€) | 0.709 - 1.764 | ||
Shares Outstanding (Mil) | 38.13 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Bolt Biotherapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Bolt Biotherapeutics Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Bolt Biotherapeutics Inc Frequently Asked Questions
What is Bolt Biotherapeutics Inc(STU:6LP)'s stock price today?
When is next earnings date of Bolt Biotherapeutics Inc(STU:6LP)?
Does Bolt Biotherapeutics Inc(STU:6LP) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |